Unlock stock picks and a broker-level newsfeed that powers Wall Street.
IOB - Delayed Quote SEK

Biotage AB (publ) (0GRP.IL)

Compare
88.45
-6.75
(-7.09%)
At close: April 4 at 4:21:29 PM GMT+1
Loading Chart for 0GRP.IL
  • Previous Close 95.20
  • Open 93.60
  • Bid 84.05 x --
  • Ask 92.85 x --
  • Day's Range 89.40 - 93.60
  • 52 Week Range 89.40 - 201.40
  • Volume 12,156
  • Avg. Volume 5,261
  • Market Cap (intraday) 8.648B
  • Beta (5Y Monthly) 0.81
  • PE Ratio (TTM) 27.47
  • EPS (TTM) 3.22
  • Earnings Date Apr 24, 2025
  • Forward Dividend & Yield 1.60 (1.84%)
  • Ex-Dividend Date Apr 28, 2023
  • 1y Target Est --

Biotage AB (publ) provides solution and product in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation product; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, academic, environmental protection, food safety, and agriculture, as well as clinical, forensic, and academic laboratories. It operates in 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.

www.biotage.com

527

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0GRP.IL

View More

Performance Overview: 0GRP.IL

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

0GRP.IL
44.89%
OMX Stockholm 30 Index (^OMX)
7.89%

1-Year Return

0GRP.IL
49.58%
OMX Stockholm 30 Index (^OMX)
9.30%

3-Year Return

0GRP.IL
60.76%
OMX Stockholm 30 Index (^OMX)
7.06%

5-Year Return

0GRP.IL
6.68%
OMX Stockholm 30 Index (^OMX)
62.84%

Compare To: 0GRP.IL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0GRP.IL

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    7.14B

  • Enterprise Value

    6.96B

  • Trailing P/E

    24.92

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.45

  • Price/Book (mrq)

    1.72

  • Enterprise Value/Revenue

    3.38

  • Enterprise Value/EBITDA

    13.13

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.90%

  • Return on Assets (ttm)

    4.66%

  • Return on Equity (ttm)

    8.27%

  • Revenue (ttm)

    1.55B

  • Net Income Avi to Common (ttm)

    216M

  • Diluted EPS (ttm)

    3.22

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    444M

  • Total Debt/Equity (mrq)

    9.99%

  • Levered Free Cash Flow (ttm)

    276.88M

Research Analysis: 0GRP.IL

View More

Company Insights: 0GRP.IL

Research Reports: 0GRP.IL

View More

People Also Watch